Navigation Links
Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
Date:12/16/2008

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the continued development of Jazz Pharmaceuticals' JZP-6 product candidate, the potential future profitability of Jazz Pharmaceuticals, and the estimated charge related to the workforce reduction. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the development of Jazz Pharmaceuticals' JZP-6 and JZP-8 product candidates, including the risk that clinical trial results may require Jazz Pharmaceuticals to discontinue their development; and risks related to the need for additional funds. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on November 14, 2008. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... Nektar Therapeutics (Nasdaq: NKTR ) announced today ... on its board of directors. Winger is ... years of experience in corporate management, financial and ... industry perspective at an important time in the ... CEO of Nektar and member of the Board ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... , , , ... This Application Note describes how Gene Logic, Inc., has ... by using,the Agilent 2100 bioanalyzer. The Eukaryote Total RNA Nano and Pico,assays ... as well as detection of possible degradation. The mRNA Smear,Nano assay is ...
... , ... , , , ... is the major,cause of chronic active gastritis,and is associated with ... PCR (mPCR) based,approach distinguished different,allelic variants that are associated,with different ...
... , ... , , , ... as research tools,(for example protein arrays) or as biopharmaceutical therapeutics. ... quality control. The key quality criteria include: protein identification,quantitation and ...
Other Biology Technology:Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 2Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 3Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 4Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 5Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 6Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 2Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 3Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 4Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 5Microfluidic analysis of multiplex,PCR products for the genotyping of,Helicobacter pylori 6Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 2Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 3
(Date:12/14/2009)... a clean-burning, renewable fuel that could help wean the ... by ozone, compared with gasoline, especially in winter, according ... , Ozone production from both gasoline and E85, a ... ethanol, is greater in warm sunny weather than during ... heat and sunlight contribute to ozone formation. But E85 ...
(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...
(Date:12/14/2009)... Technology Partners, a global software company that automates ... the Pharmaceutical industry, today announced the general availability ... data acquisition platform. The latest release enables quality ... manufacturing processes. ,, MODA 3.0 includes the ... Methods: Each test method in the MODA ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 1One in 10 High School Seniors Have Used Narcotic Painkillers 53538 2One in 10 High School Seniors Have Used Narcotic Painkillers 53538 3Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 1Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 2Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 53536 3Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin 53534 1Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin 53534 2
... therapeutic cancer vaccine combining the synthetic bacterial DNA sequence, ... were reported today in the Journal of Clinical Investigation. ... is safe, and increases the immune system's ability to ... was conducted by the Lausanne Branch of the Ludwig ...
... , ,Oncologists have long thought that cancer ... of day. But they have been unable to turn ... the phenomenon well enough. Now, researchers have discovered a ... changes with the clock. They said their findings could ...
... Expression Project for Oncology (expO) has released clinically ... completing the initial phase of the nation’s first ... gene expression data. The clinically annotated dataset is ... Center for Biotechnology Information web site at www.ncbi.nlm.nih.gov/geo/. ...
Other Biology News:Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy 2Effective Cancer Treatments Follow The Clock 2Effective Cancer Treatments Follow The Clock 3Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 2Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 3
...
... TURRAX Tube Disperser System from IKA Works is ... a cleaner, safer, and more efficient way to ... from 2 to 15 ml inside sealed tubes. ... one of 4 different tube types. Each tube ...
...
... light scattering detector for ambient HPLC. ... processing hardware for two external devices ... Also contains an analog output from ... strip chart recorders. Includes an input ...
Biology Products: